Low Dose Mirena Study

Research status

Completed

Overview of Study

A study to assess the efficacy, safety & bleeding pattern of low dose (LNG) Progesterone (12 mg/24 hrs), delivered locally by a new intrauterine contraceptive system (IUS) suitable for use by women 18 to 40 years of age.

Objectives of study

Women in need of low maintenance contraception were invited to participate in this study. Participation in this project will last for a maximum of 3 years and will involve a screening phase, baseline visit (when the LCS will be inserted), 4 visits performed every 3 months for the first year and 4 visits performed every 6 months for the subsequent 2 years.